biote Corp. (BTMD)
(Delayed Data from NSDQ)
$5.23 USD
+0.13 (2.55%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $5.24 +0.01 (0.19%) 7:58 PM ET
2-Buy of 5 2
A Value A Growth F Momentum A VGM
biote Corp. (BTMD) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$9.59 | $12.00 | $7.00 | 88.04% |
Price Target
Based on short-term price targets offered by five analysts, the average price target for biote Corp. comes to $9.59. The forecasts range from a low of $7.00 to a high of $12.00. The average price target represents an increase of 88.04% from the last closing price of $5.10.
Analyst Price Targets (5 )
Broker Rating
biote Corp. currently has an average brokerage recommendation (ABR) of 1.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by five brokerage firms. The current ABR compares to an ABR of 1.00 a month ago based on five recommendations.
Of the five recommendations deriving the current ABR, five are Strong Buy, representing 100% of all recommendations. A month ago, Strong Buy represented 100%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 5 | 5 | 5 | 5 | 5 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
8/21/2024 | B. Riley Securities | Jeffrey W Van Sinderen | Strong Buy | Strong Buy |
8/19/2024 | Cowen & Co. | Jonna Kim | Strong Buy | Strong Buy |
8/8/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
6/21/2024 | Roth Capital Partners | George Kelly | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.00 |
ABR (Last week) | 1.00 |
# of Recs in ABR | 5 |
Average Target Price | $9.59 |
LT Growth Rate | NA |
Industry | Medical - Products |
Industry Rank by ABR | 74 of 252 |
Current Quarter EPS Est: | 0.09 |
BTMD FAQs
biote Corp. (BTMD) currently has an average brokerage recommendation (ABR) of 1.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 5 brokerage firms.
The average price target for biote Corp. (BTMD) is $9.59. The current on short-term price targets is based on 2 reports.
The forecasts for biote Corp. (BTMD) range from a low of $7 to a high of $12. The average price target represents a increase of $83.37 from the last closing price of $5.23.
The current UPSIDE for biote Corp. (BTMD) is 83.37%
Based on short-term price targets offered by five analysts, the average price target for biote Corp. comes to $9.59. The forecasts range from a low of $7.00 to a high of $12.00. The average price target represents an increase of 88.04% from the last closing price of $5.10.